| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |